High throughput assay for novel pharmacological probes targeting cAMP signaling
针对 cAMP 信号传导的新型药理学探针的高通量测定
基本信息
- 批准号:7991500
- 负责人:
- 金额:$ 15.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AgonistBindingBiochemicalBiological AssayBiological ProcessCellsCyclic AMPCyclic AMP ReceptorsCyclic AMP-Dependent Protein KinasesDiabetes MellitusDimensionsDiseaseEnvironmentEukaryotic CellFluorescenceGoalsGuanine Nucleotide Exchange FactorsGuanine NucleotidesHeart failureIntracellular Second MessengerLeadLibrariesLifeMalignant NeoplasmsMeasuresMediatingMedicalMolecularMolecular ProbesMonitorPhysiologicalPlayProteinsReactionRegulationResearchScreening procedureSecond Messenger SystemsSignal TransductionSpecificitySystemTestingTherapeuticTissuesassay developmentbasedesignhigh throughput screeninginnovationnovelphosphoric diester hydrolasepotency testingprogramspublic health relevanceresearch studysecond messengertool
项目摘要
DESCRIPTION (provided by applicant): cAMP-mediated cell signaling regulates a myriad of important biological processes under both physiological and pathological conditions, including diabetes, heart failure, and cancer. In eukaryotic cells, the effects of cAMP are transduced by two intracellular cAMP receptors, the classic protein kinase A/cAMP-dependent protein kinase (PKA/cAPK) and the recently discovered exchange protein directly activated by cAMP/cAMP-regulated guanine nucleotide exchange factor (Epac/cAMP-GEF). Like PKA, Epac contains a cAMP-binding domain, an evolutionally conserved structural motif that acts as a molecular switch for sensing intracellular second messenger cAMP levels. The discovery of Epac has opened a new dimension in studying the cAMP-mediated signaling as both PKA and Epac are ubiquitously expressed in all tissues. An increase in intracellular cAMP levels will lead to the activation of both PKA and Epac. Therefore, the net cellular effects of cAMP are not just dictated by PKA or Epac alone, but dependent upon the dynamic expression of Epac and PKA and their specific subcellular distribution in a particular tissue. Currently, the physiological functions of Epac are not clear. One of the major challenges within the research field is the lack of Epac-specific antagonists to dissect the specific physiological functions that Epac play in the overall cAMP-mediated signaling. The objective of this proposal is to develop a High Throughput Screening (HTS) assay for the discovery of novel molecular probes that are specific for Epac but not PKA. These Epac-specific probes will be powerful pharmacological tools for investigating the biological functions of Epac and molecular mechanism of cAMP signaling as well as, for promoting an understanding of disease mechanisms related to Epac/cAMP signaling.
PUBLIC HEALTH RELEVANCE: The goal of our proposed research is to develop a High Throughput Screening assay for the discovery of novel target-specific pharmacological probes that can be used for elucidating the mechanism of signal transduction mediated by an important second messenger, cAMP. The medical and pharmacological implications of this research program are far-reaching. Novel pharmacological probes targeting specific cAMP signaling components can potentially lead to the identification of mechanism-based therapeutic strategies for diseases associated with cAMP signaling.
描述(由申请人提供):cAMP介导的细胞信号传导调节生理和病理条件下的无数重要生物过程,包括糖尿病、心力衰竭和癌症。在真核细胞中,cAMP的作用通过两种胞内cAMP受体转导,经典的蛋白激酶A/cAMP依赖性蛋白激酶(PKA/cAPK)和最近发现的由cAMP/cAMP调节的鸟嘌呤核苷酸交换因子直接激活的交换蛋白(Epac/cAMP-GEF)。与PKA一样,Epac含有cAMP结合结构域,这是一种进化上保守的结构基序,作为感知细胞内第二信使cAMP水平的分子开关。Epac的发现为研究cAMP介导的信号传导开辟了新的维度,因为PKA和Epac在所有组织中普遍表达。细胞内cAMP水平的增加将导致PKA和Epac的激活。因此,cAMP的净细胞效应不仅仅由PKA或Epac单独决定,而是取决于Epac和PKA的动态表达及其在特定组织中的特定亚细胞分布。目前,Epac的生理功能尚不清楚。研究领域内的主要挑战之一是缺乏Epac特异性拮抗剂来剖析Epac在整个cAMP介导的信号传导中发挥的特定生理功能。本提案的目的是开发一种高通量筛选(HTS)检测方法,用于发现对Epac特异而非PKA特异的新型分子探针。这些Epac特异性探针将为研究Epac的生物学功能和cAMP信号传导的分子机制以及促进对Epac/cAMP信号传导相关疾病机制的理解提供有力的药理学工具。
公共卫生相关性:我们提出的研究的目标是开发一种高通量筛选试验,用于发现新的靶向特异性药理学探针,可用于阐明由重要的第二信使cAMP介导的信号转导机制。这项研究计划的医学和药理学意义深远。靶向特定cAMP信号传导组分的新型药理学探针可能导致识别与cAMP信号传导相关的疾病的基于机制的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIAODONG CHENG其他文献
XIAODONG CHENG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIAODONG CHENG', 18)}}的其他基金
Significance of Epac signaling in renal Na+ handling and hypertension
Epac 信号在肾钠处理和高血压中的意义
- 批准号:
10864073 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Epac1 as a novel therapeutic target for diabetic retinopathy
Epac1作为糖尿病视网膜病变的新型治疗靶点
- 批准号:
10689112 - 财政年份:2022
- 资助金额:
$ 15.3万 - 项目类别:
Exchange Protein directly Activated by cAMP (EPAC): Structure, Function and Therapeutics
cAMP 直接激活的交换蛋白 (EPAC):结构、功能和治疗
- 批准号:
10198941 - 财政年份:2017
- 资助金额:
$ 15.3万 - 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
- 批准号:
9250048 - 财政年份:2014
- 资助金额:
$ 15.3万 - 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
- 批准号:
9038248 - 财政年份:2014
- 资助金额:
$ 15.3万 - 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
- 批准号:
8694342 - 财政年份:2014
- 资助金额:
$ 15.3万 - 项目类别:
Novel Pharmacological Probes Targeting Exchange Proteins Activated by cAMP (EPAC)
针对 cAMP 激活的交换蛋白的新型药理学探针 (EPAC)
- 批准号:
8482964 - 财政年份:2013
- 资助金额:
$ 15.3万 - 项目类别:
High throughput assay for novel pharmacological probes targeting cAMP signaling
针对 cAMP 信号传导的新型药理学探针的高通量测定
- 批准号:
8477859 - 财政年份:2010
- 资助金额:
$ 15.3万 - 项目类别:
Genetic Screening:Oncogene RAS-Based Inhibi*(RMI)
基因筛查:Oncogene RAS-Based Inhibi*(RMI)
- 批准号:
7058055 - 财政年份:2005
- 资助金额:
$ 15.3万 - 项目类别:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
Epac/cAMP-GEF,一种新型细胞内 cAMP 受体
- 批准号:
6743684 - 财政年份:2003
- 资助金额:
$ 15.3万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Biochemical characterization of an inflammation related protein, mTOC (Celastramycin binding protein)
炎症相关蛋白 mTOC(西拉霉素结合蛋白)的生化特征
- 批准号:
17K07346 - 财政年份:2017
- 资助金额:
$ 15.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of the impact of Arginine Methylation of RNA Binding Proteins on Their Biochemical
RNA 结合蛋白精氨酸甲基化对其生化影响的表征
- 批准号:
511321-2017 - 财政年份:2017
- 资助金额:
$ 15.3万 - 项目类别:
University Undergraduate Student Research Awards
Biochemical & Genetic Analysis of Low Complexity Domains in RNA-binding protein biology
生化
- 批准号:
9335978 - 财政年份:2016
- 资助金额:
$ 15.3万 - 项目类别:
Biochemical & Genetic Analysis of Low Complexity Domains in RNA-binding protein biology
生化
- 批准号:
9158657 - 财政年份:2016
- 资助金额:
$ 15.3万 - 项目类别:
EAGER: Biochemical Mechanism of Oomycete RXLR Effector Binding to PI3P
EAGER:卵菌 RXLR 效应子与 PI3P 结合的生化机制
- 批准号:
1449122 - 财政年份:2014
- 资助金额:
$ 15.3万 - 项目类别:
Standard Grant
Biochemical analysis of plant calcium-binding proteins
植物钙结合蛋白的生化分析
- 批准号:
448832-2013 - 财政年份:2013
- 资助金额:
$ 15.3万 - 项目类别:
University Undergraduate Student Research Awards
Genetic and biochemical analysis of the CaMK family of calmodulin-binding kinases in root and nodule function of Glycine max and Medicago truncatula
钙调蛋白结合激酶 CaMK 家族在大豆和蒺藜苜蓿根和根瘤功能中的遗传和生化分析
- 批准号:
409766-2011 - 财政年份:2013
- 资助金额:
$ 15.3万 - 项目类别:
Postgraduate Scholarships - Doctoral
Genetic and biochemical analysis of the CaMK family of calmodulin-binding kinases in root and nodule function of Glycine max and Medicago truncatula
钙调蛋白结合激酶 CaMK 家族在大豆和蒺藜苜蓿根和根瘤功能中的遗传和生化分析
- 批准号:
409766-2011 - 财政年份:2012
- 资助金额:
$ 15.3万 - 项目类别:
Postgraduate Scholarships - Doctoral
Biochemical, cellular and molecular studies to dissect the contribution of the soluble host carbohydrate binding proteins to HIV-1 pathogenesis
生化、细胞和分子研究,剖析可溶性宿主碳水化合物结合蛋白对 HIV-1 发病机制的贡献
- 批准号:
239201 - 财政年份:2011
- 资助金额:
$ 15.3万 - 项目类别:
Operating Grants
Genetic and biochemical analysis of the CaMK family of calmodulin-binding kinases in root and nodule function of Glycine max and Medicago truncatula
钙调蛋白结合激酶 CaMK 家族在大豆和蒺藜苜蓿根和根瘤功能中的遗传和生化分析
- 批准号:
409766-2011 - 财政年份:2011
- 资助金额:
$ 15.3万 - 项目类别:
Postgraduate Scholarships - Doctoral